Prolonged damage of nerve cells due to inflammation in nose responsible for sense of smell in COVID19 Dr. Kamal Kant Kohli2 Jan 2023 4:00 AM GMTThe reason some people fail to recover their sense of smell after COVID-19 is linked to an ongoing immune assault on olfactory nerve cells and an...
Cholesterol drug Statins provide protective immune function in females Dr. Kamal Kant Kohli25 Aug 2022 2:30 PM GMTCatherine Andersen, associate professor of nutritional sciences in the College of Agriculture, Health and Natural Resources has found in a new study...
Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2 Dr. Kamal Kant Kohli16 May 2022 6:15 AM GMTThe omicron (B.1.1.529) variant of SARS-CoV-2, has spread rapidly around the world and has already become the predominant variant circulating in many...
Fourth dose of Pfizer vaccine may provide additional protection to elderly against severe disease: NEJM Medical Dialogues Editorial Team8 April 2022 4:30 AM GMTIsrael: A new study conducted by Yinon M. Bar-On and the team found that after the fourth dose of BNT162b2 vaccination, rates of confirmed SARS-CoV-2...
Decoding REGEN-COV2 for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients Dr. Kamal Kant Kohli17 March 2022 6:15 AM GMTKidney transplant recipients are an immunocompromised population, with comorbid conditions such as obesity, diabetes, and coronary artery disease,...
Casirivimab and imdevimab in patients admitted to hospital with COVID-19: RECOVERY Trial Dr. Kamal Kant Kohli9 March 2022 11:49 AM GMTCasirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor-binding domain of the SARS-CoV-2...
Decoding safety, tolerability, and pharmacokinetics of Molnupiravir Dr. Kamal Kant Kohli4 Feb 2022 6:26 AM GMTMolnupiravir is a prodrug of active antiviral ribonucleoside analog b-D-N4-hydroxycytidine (NHC; EIDD-1931), with the potential to treat infections...
Quick Review: Effectiveness of REGEN-COV antibody cocktail against B.1.617.2 (delta) variant of SARS-CoV-2 Dr. Kamal Kant Kohli1 Feb 2022 7:04 AM GMTCasirivimab plus imdevimab antibody cocktail (REGEN-COV) has been shown to reduce viral load and prevent symptomatic disease in household contacts of...
Molnupiravir (MK-4482/EIDD-2801) inhibits SARS-CoV-2 replication in Syrian Hamster Model Dr. Kamal Kant Kohli25 Jan 2022 5:34 AM GMTAn effective antiviral against SARS-CoV-2 that could be administered orally for use following high-risk exposure would be of substantial benefit in...
Infants Born To COVID-19 Infected Mothers don't lag In Growth And Neurodevelopment: Study dr anusha23 Sep 2021 3:30 AM GMTSevere acute respiratory syndrome coronavirus 2 (SARSCoV-2) -positive neonates who were symptomatic had predominant respiratory symptoms attributed to...
The SARS-CoV-2 vaccine provides cross-protection to the unvaccinated: Study Dr. Shravani Dali2 Aug 2021 3:30 AM GMTAlong with vaccinated individuals, the SARS-CoV-2 vaccine also protects the unvaccinated people within the locality, according to a study published...
Pfizer vaccine may reduce risk of COVID-19 infection in pregnant women: JAMA Dr Satabdi Saha15 July 2021 3:30 AM GMTPfizer-BioNTech mRNA vaccination compared with no vaccination was associated with a significantly lower risk of SARS-CoV-2 infection in pregnant...
